ARYx Therapeutics, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

Late annual filing notification for FY 2010

ended 09/30/10 Q3

ended 06/30/10 Q2

ended 03/31/10 Q1

ended 12/31/09 FY 2009

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Shelf registration

Registration of securities for employees

Exempt offering of securities

Ownership Filter

Prudential Financial Inc.

Growth Equity Opportunities Fund, LLC

Newhall Charles W III, Kramlich C Richard, Barris Peter J, Perry Mark W, Barrett M James, Sandell Scott D, Nea 12 GP, LLC, NEA Partners 12, Limited Partnership, New Enterprise Associates 12, Limited Partnership, Growth Equity Opportunities Fund, LLC

News Filter

Increase/Acceleration of Financial Obligation or Off-Balance Sheet Arrangement

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Change in Directors, Officers or Compensation

Informed of Additional Delay by FDA and Begins Wind-Down of Operations

Change in Directors, Officers or Compensation

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness